__NUXT_JSONP__("/drugs/Almonertinib", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"1899921-05-1",chebiId:b,chemicalFormula:b,definition:"An orally available inhibitor of the epidermal growth factor receptor (EGFR) mutant form T790M, with potential antineoplastic activity. Upon administration, almonertinib binds to and inhibits EGFR T790M, a secondarily acquired resistance mutation, inhibits the tyrosine kinase activity of EGFR T790M, prevents EGFR T790M-mediated signaling and leads to cell death in EGFR T790M-expressing tumor cells. EGFR, a receptor tyrosine kinase that is mutated in many tumor cell types, plays a key role in tumor cell proliferation and tumor vascularization.",fdaUniiCode:"T4RS462G19",identifier:"C133691",preferredName:a,semanticType:"Pharmacologic Substance",subclassOf:["C129825","C2167"],synonyms:["ALMONERTINIB",a,"EGFR Tyrosine Kinase Inhibitor HS-10296","HS-10296"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FAlmonertinib",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Almonertinib","","2021-10-30T13:31:45.323Z")));